CellTrack
Madison, US · Founded 2026 · Delaware corporation · 1 known investors
CellTrack develops a cell-labeling technology that attaches Zirconium-89 to therapeutic cells for non-invasive PET imaging, allowing tracking of cell biodistribution in vivo for over 7 days. The company targets pharma companies and CDMOs developing cell therapies, aiming to provide biodistribution data for clinical trials.
BiotechHealthtechMedical Devices
Founders & leadership
Board
RD
Robert DrapeBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$30K disclosed across 1 round · 2026
▶$30KraisedJul 2026 · 1 investors · BiotechnologyRule 506(b)
▶$30KraisedJul 2026 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Victor Santoro FernandesExecutive Officer, Director
- Reinier HernandezDirector
- Robert DrapeDirector
- Offering amount
- $600K
- Amount sold
- $30K
- Minimum investment
- $5K
- First sale
- Jul 2026
- Incorporated
- Corporation, Delaware, 2026
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does CellTrack do?
- CellTrack develops a cell-labeling technology that attaches Zirconium-89 to therapeutic cells for non-invasive PET imaging, allowing tracking of cell biodistribution in vivo for over 7 days. The company targets pharma companies and CDMOs developing cell therapies, aiming to provide biodistribution data for clinical trials.
- Who are CellTrack's investors?
- CellTrack's investors include Gener8tor.
- How much funding has CellTrack raised?
- CellTrack has disclosed $30K raised across 1 round.
- Where is CellTrack headquartered?
- CellTrack is headquartered in Madison, US.